320 related articles for article (PubMed ID: 15312251)
1. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin.
Daroszewska A; Hocking LJ; McGuigan FE; Langdahl B; Stone MD; Cundy T; Nicholson GC; Fraser WD; Ralston SH
J Bone Miner Res; 2004 Sep; 19(9):1506-11. PubMed ID: 15312251
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.
Lucas GJ; Mehta SG; Hocking LJ; Stewart TL; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Watts GD; Ralston SH; Kimonis VE
Bone; 2006 Feb; 38(2):280-5. PubMed ID: 16199218
[TBL] [Abstract][Full Text] [Related]
3. Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders.
Lucas GJ; Daroszewska A; Ralston SH
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P31-7. PubMed ID: 17229006
[TBL] [Abstract][Full Text] [Related]
4. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone.
Beyens G; Daroszewska A; de Freitas F; Fransen E; Vanhoenacker F; Verbruggen L; Zmierczak HG; Westhovens R; Van Offel J; Ralston SH; Devogelaer JP; Van Hul W
J Bone Miner Res; 2007 Jul; 22(7):1062-71. PubMed ID: 17388729
[TBL] [Abstract][Full Text] [Related]
5. Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels.
Whyte MP; Singhellakis PN; Petersen MB; Davies M; Totty WG; Mumm S
J Bone Miner Res; 2007 Jun; 22(6):938-46. PubMed ID: 17352649
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.
Langdahl BL; Carstens M; Stenkjaer L; Eriksen EF
J Bone Miner Res; 2002 Jul; 17(7):1245-55. PubMed ID: 12096838
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Paget's disease of bone.
Daroszewska A; Ralston SH
Clin Sci (Lond); 2005 Sep; 109(3):257-63. PubMed ID: 16104845
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin deficiency and juvenile Paget's disease.
Whyte MP; Obrecht SE; Finnegan PM; Jones JL; Podgornik MN; McAlister WH; Mumm S
N Engl J Med; 2002 Jul; 347(3):175-84. PubMed ID: 12124406
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.
Lucas GJ; Hocking LJ; Daroszewska A; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Meier C; Hooper MJ; Ralston SH
J Bone Miner Res; 2005 Feb; 20(2):227-31. PubMed ID: 15647816
[TBL] [Abstract][Full Text] [Related]
10. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.
Whyte MP
Ann N Y Acad Sci; 2006 Apr; 1068():143-64. PubMed ID: 16831914
[TBL] [Abstract][Full Text] [Related]
11. An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation.
Janssens K; de Vernejoul MC; de Freitas F; Vanhoenacker F; Van Hul W
Bone; 2005 Mar; 36(3):542-8. PubMed ID: 15777670
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.
Chong B; Hegde M; Fawkner M; Simonet S; Cassinelli H; Coker M; Kanis J; Seidel J; Tau C; Tüysüz B; Yüksel B; Love D;
J Bone Miner Res; 2003 Dec; 18(12):2095-104. PubMed ID: 14672344
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of disease: genetics of Paget's disease of bone and related disorders.
Daroszewska A; Ralston SH
Nat Clin Pract Rheumatol; 2006 May; 2(5):270-7. PubMed ID: 16932700
[TBL] [Abstract][Full Text] [Related]
14. Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders.
Ralston SH
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):101-11. PubMed ID: 18328984
[TBL] [Abstract][Full Text] [Related]
15. Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy.
Rendina D; Gennari L; De Filippo G; Merlotti D; de Campora E; Fazioli F; Scarano G; Nuti R; Strazzullo P; Mossetti G
J Bone Miner Res; 2006 Dec; 21(12):1828-35. PubMed ID: 17002563
[TBL] [Abstract][Full Text] [Related]
16. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease.
Beyens G; Van Hul E; Van Driessche K; Fransen E; Devogelaer JP; Vanhoenacker F; Van Offel J; Verbruggen L; De Clerck L; Westhovens R; Van Hul W
Calcif Tissue Int; 2004 Aug; 75(2):144-52. PubMed ID: 15164150
[TBL] [Abstract][Full Text] [Related]
18. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL.
Middleton-Hardie C; Zhu Q; Cundy H; Lin JM; Callon K; Tong PC; Xu J; Grey A; Cornish J; Naot D
J Bone Miner Res; 2006 Mar; 21(3):438-45. PubMed ID: 16491292
[TBL] [Abstract][Full Text] [Related]
19. Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms.
Chung PY; Beyens G; de Freitas F; Boonen S; Geusens P; Vanhoenacker F; Verbruggen L; Van Offel J; Goemaere S; Zmierczak HG; Westhovens R; Devogelaer JP; Van Hul W
Mol Genet Metab; 2011 Jul; 103(3):287-92. PubMed ID: 21501964
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the role of RANK and OPG genes in Paget's disease of bone.
Wuyts W; Van Wesenbeeck L; Morales-Piga A; Ralston S; Hocking L; Vanhoenacker F; Westhovens R; Verbruggen L; Anderson D; Hughes A; Van Hul W
Bone; 2001 Jan; 28(1):104-7. PubMed ID: 11165949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
